Should I Buy XCUR? XCUR 2026 Analysis

Should You Buy Exicure Inc (XCUR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

4.260

1 Day change

1.67%

52 Week Range

15.910

Analysis Updated At

2026/01/26

Exicure Inc (XCUR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows no significant positive momentum, and insider selling trends, weak financial performance, and lack of proprietary trading signals suggest caution. For now, holding off on investment is recommended until stronger signals or catalysts emerge.

Technical Analysis

The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 53.284, showing no clear overbought or oversold conditions. The stock is trading near its support level (S1: 5.776), with pre-market price at 5.85, down 5.03%. Moving averages are converging, suggesting indecision in the market.

Options Data

Positive Catalysts

The company announced promising Phase 2 trial results for burixafor, showing an 89.7% success rate in autologous hematopoietic cell transplantation for multiple myeloma patients. This could be a long-term positive catalyst if the drug progresses successfully.

Neutral/Negative Catalysts

Insiders are selling heavily, with a 106.79% increase in selling activity over the last month. Financial performance remains weak, with negative EPS (-0.39) and gross margin (0). The pre-market price is down 5.03%, reflecting negative sentiment.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth YoY. Net income improved to -$2,437,000 (up 123.37% YoY), but the company is still unprofitable. EPS dropped to -0.39, down 31.58% YoY, and gross margin fell to 0, down 100%. Overall, the financials indicate ongoing challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent updates on analyst ratings or price target changes. Wall Street sentiment appears neutral to negative, given the lack of significant positive developments and insider selling trends.

Analyst Rating

Wall Street analysts forecast XCUR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XCUR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 4.190

Low

Averages

High